Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Captor Therapeutics secures USD 2 million non-dilutive grant from The Michael J. Fox Foundation for its NEK7 neurodegenerative disease project.
Amount Raised
$2 Million
Round Type
Grant
Investors
Description
Captor Therapeutics secured a USD 2 million grant from The Michael J. Fox Foundation on September 29, 2026, to support development of a brain-penetrant NEK7 candidate for neurodegenerative diseases, including Parkinson's disease. The non-dilutive award does not result in share dilution or convertible debt issuance. Captor retains intellectual property rights connected with the NEK7 project
Fundz sees it the moment Captor Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Captor Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.